Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 31, 2026 18:56 ET | Source: Hagens Berman Sobol Shapiro LLP

Coty Inc. (COTY) Faces Securities Class Action Amid Surprise YoY Deterioration in Operating Income, CEO Departure, Withdrawn Guidance -- Hagens Berman

Investors who lost money in COTY after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 31, 2026 18:53 ET | Source: Hagens Berman Sobol Shapiro LLP

PYPL INVESTOR UPDATE: Hagens Berman Alerts PayPal (PYPL) Investors to Securities Class Action Following CEO Ouster and $10B Market Cap Wipeout

Investors who lost money in PYPL after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 31, 2026 18:45 ET | Source: Hagens Berman Sobol Shapiro LLP

Eos Energy Enterprises (EOSE) Faces Securities Class Action Amid Analyst Questions Over Management’s Transparency, Shares Crater 39% -- Hagens Berman

Investors who lost money in EOSE after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 27, 2026 21:34 ET | Source: Hagens Berman Sobol Shapiro LLP

ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating

Investors who lost money in ADMA after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 27, 2026 18:47 ET | Source: Hagens Berman Sobol Shapiro LLP

ImmunityBio, Inc. (IBRX) Faces Securities Class Action Amid FDA Warning Regarding Unsupported Cancer Treatment Claims, $2 Billion Market Capitalization Wiped Out – Hagens Berman

Investors who lost money in IBRX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 27, 2026 14:35 ET | Source: Hagens Berman Sobol Shapiro LLP

KD INVESTOR ALERT: New Kyndryl (KD) Securities Class Action Complaint Expands Class Period to August 1, 2024– Hagens Berman

Investors who lost money in KD after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 27, 2026 14:30 ET | Source: Hagens Berman Sobol Shapiro LLP

QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data

Investors who lost money in QURE after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 27, 2026 14:26 ET | Source: Hagens Berman Sobol Shapiro LLP

CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 27, 2026 14:26 ET | Source: Hagens Berman Sobol Shapiro LLP

APO SHAREHOLDER NOTICE: Hagens Berman Alerts Apollo Global Management (APO) Investors to Securities Class Action Stemming From “Epstein Files” Revelations

Investors who lost money in APO after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 27, 2026 14:23 ET | Source: Hagens Berman Sobol Shapiro LLP

Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements

Investors who lost money in ZYXI after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.